Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Cell Culture PD - Parallel System for Cell Culture Process Development

Product Image
Product Description

DASGIP Parallel Bioreactor Systems for process development with animal and insect as well as with human cell lines allow for advanced process control and automation.

Precise control of all relevant process parameters, user-defined profiles and innumerable automation features result in accelerated and highly efficient process development. Industry-leading communication standards support DoE, process historians and comprehensive data management.

Individual systems can be configured with assorted components and software functions to meet specific application requirements:

  • Parallel operation of four, eight or sixteen bioreactors
  • Excellent growth of e.g. CHO, Hybridoma and NS0 cell lines
  • Excellent scalability and reproducibility
  • Support of high cell densities up to 2x10^7 cells per mL
  • Small footprint achieved through using compact stackable modules
  • Predefined recipes for standard applications
  • Full controller scripting for easy scale-up and scale-down
  • Variable speed pump drives
  • Continuous and cyclic perfusion templates
  • Overhead drives
  • Individual temperature control via Heating Blanket and/or Cooling Finger
  • pH control using acid and base or CO2 and base
  • pO2 control with constant gassing or gassing on demand
  • Individual gas mixture from Air, O2, CO2 and N2
  • Thermal Mass Flow controlled gassing
  • Cascaded pO2 control using gas flow rates and oxygen enchrichment
  • Gassing to headspace, sparger and/or overlay
  • Level control and/or anti foam sensor
  • Optional integration to bioprocess analyzer, cell counter, HPLC, etc.
  • In-situ cell growth monitoring (optical density)
Product Cell Culture PD - Parallel System for Cell Culture Process Development
Company DASGIP
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

DASGIP
Rudolf-Schulten-Str. 5 52428 Jülich Germany

Tel: +49 (0)2461-980-0

Email: info@dasgip.de



Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!